Theravance (THRX) released an updated registration statement for its spinoff stating that investors will receive one ordinary share of Theravance Biopharma for every 3.5 shares of Theravance common stock that they own.
Spin-Off
Theravance (THRX) released an updated registration statement for its spinoff stating that investors will receive one ordinary share of Theravance Biopharma for every 3.5 shares of Theravance common stock that they own.